VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
S.F. Holding Co., Ltd. vs Amgen Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
S.F. Holding Co., Ltd.
002352 · Shenzhen Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into S.F. Holding Co., Ltd.'s moat claims, evidence, and risks.
View 002352 analysisAmgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: S.F. Holding Co., Ltd. leads (75 / 100 vs 70 / 100 for Amgen Inc.).
- Segment focus: S.F. Holding Co., Ltd. has 7 segments (43% in Time-definite Express); Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines).
- Primary market structure: Quasi-Monopoly vs Competitive. Pricing power: Strong vs Moderate.
- Moat breadth: S.F. Holding Co., Ltd. has 9 moat types across 3 domains; Amgen Inc. has 5 across 3.
Primary market context
S.F. Holding Co., Ltd.
Time-definite Express
Premium time-definite parcel express delivery services
China
B2B, B2C
Integrated parcel pickup, sorting, line-haul, and last-mile delivery
43%
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Side-by-side metrics
Moat coverage
Shared moat types
S.F. Holding Co., Ltd. strengths
Amgen Inc. strengths
Segment mix
S.F. Holding Co., Ltd. segments
Full profile >Time-definite Express
Quasi-Monopoly
Economy Express
Oligopoly
LTL Freight
Competitive
Cold Chain & Pharmaceutical
Competitive
Intra-city On-demand
Oligopoly
Supply Chain & International
Competitive
Other (Non-logistics & Undistributed Units)
Competitive
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.